title: Effects of age of onset on disease characteristics in non-segmental vitiligo.
abstract: In patients with vitiligo, the clinical and laboratory features of the disease may vary according to time of onset. This is addressed in the literature by only a few studies with conflicting results. The aim of this study was to determine the demographic and clinical features of patients with non-segmental vitiligo and to establish the association between vitiligo and autoimmune diseases with a focus on time of disease onset. A total of 224 vitiligo patients for whom complete medical records were available were evaluated retrospectively. Demographic data, scores on the Vitiligo Area Score Index (VASI), clinical features, vitiligo disease activity, repigmentation status, presence of any accompanying autoimmune disease, antinuclear antibody (ANA) titers, serum levels of glucose, thyroid-stimulating hormone (TSH), thyroxine (T4) hormone, anti-thyroid peroxidase (anti-TPO), and anti-thyroglobulin (anti-TG) were recorded. The prevalence of halo nevi was significantly higher (P < 0.001) among children than in other patient groups. The prevalence of leukotrichia was higher in adults with adult-onset disease than in either pediatric patients or adults with childhood-onset disease (P = 0.002). Both anti-TG and anti-TPO levels were significantly higher in adults with adult-onset disease than in pediatric patients and adult patients with childhood-onset disease. The prevalence of autoimmune disease was 22.2%. Anti-TG levels were significantly higher in patients with treatment-related repigmentation than in those without repigmentation. This study shows that clinical features and associations with autoimmune disease may vary according to the age of onset of vitiligo.
authors.affiliation: Department of Dermatology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
authors.forename: Berna
authors.initials: B
authors.lastname: Solak
authors.affiliation: Department of Dermatology, Sakarya University Training and Research Hospital, Sakarya, Turkey.
authors.forename: Bahar Sevimli
authors.initials: BS
authors.lastname: Dikicier
authors.affiliation: Department of Dermatology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
authors.forename: Nur C
authors.initials: NC
authors.lastname: Cosansu
authors.affiliation: Department of Dermatology, Faculty of Medicine, Sakarya University, Sakarya, Turkey.
authors.forename: Teoman
authors.initials: T
authors.lastname: Erdem
mesh_terms: D000293:Adolescent; D000328:Adult; D017668:Age of Onset; D000368:Aged; D000974:Antibodies, Antinuclear / Q000097:blood; D001323:Autoantibodies / Q000097:blood; D001327:Autoimmune Diseases / Q000453:epidemiology*; D001786:Blood Glucose / Q000378:metabolism; D002648:Child; D002675:Child, Preschool; D015897:Comorbidity; D005260:Female; D006201:Hair Diseases / Q000453:epidemiology; D006801:Humans; D008297:Male; D008875:Middle Aged; D055882:Nevus, Halo / Q000453:epidemiology*; D015995:Prevalence; D012189:Retrospective Studies; D012720:Severity of Illness Index; D012878:Skin Neoplasms / Q000453:epidemiology*; D012880:Skin Pigmentation; D013972:Thyrotropin / Q000097:blood; D013974:Thyroxine / Q000097:blood; D014421:Turkey / Q000453:epidemiology; D014820:Vitiligo / Q000097:blood* / Q000453:epidemiology* / Q000503:physiopathology; D055815:Young Adult
chemical_list: D000974:Antibodies, Antinuclear; D001323:Autoantibodies; D001786:Blood Glucose; C006606:anti-thyroglobulin; C056626:thyroid microsomal antibodies; D013972:Thyrotropin; D013974:Thyroxine